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Immunoassays forthe detection ofviral antigens in clinical specimens and virus-specific IgM
responses in serum have shortened the time required to make a laboratory diagnosis of several
infections. A range ofantigen detection systems are available, varying in sensitivity, complex-
ity, and expense, and each may have a role to play depending upon the laboratory setting.
Technical advancements to eliminate false-positive results in solid-phase IgM assays have pro-
vided an awareness of very early IgM responses in diseases such as rubella, hepatitis A, and
mumps. When clinical specimens contain large numbers ofvirus particles, a rapid diagnosis is
easily made using electron microscopy. Detection of antigens, virus particles, and IgM
responses is creating increased demands for viral diagnostic services in primary care settings.
Other approaches using sensitive probes for viral nucleic acids or enzymes will also serve as
viable laboratory techniques in the future.
DETECTION OF ANTIGENS
Table 1 summarizes several reported techniques for the detection ofviral antigens.
Gel diffusion, rheophoresis, and immunoelectrophoresis (IEOP) employ gels in
which antigen and antibody movetoward each other, resulting in a line ofprecipita-
tion. Thin-layer immunoassay (TIA) involves the adsorption of a thin layer of
globulins onto a polystyrene surface [1,2]. This surface then has the characteristics
of an immunosorbent which is able to bind antigens. The antigen/antibody interac-
tion is visualized on the plate by exposing it to water vapor. Immune complexes are
hydrophilic and the background is hydrophobic; thus differences in condensation
patterns are easily recognizable to the naked eye. Latex agglutination (LA), indirect
hemagglutination inhibition (IHI) or reverse passivehemagglutination (RPHA), and
solid-phase aggregation of coated erythrocytes (SPACE) [3] are all based on the
principle of coating a visible marker such as latex particles or erythrocytes with an-
tibody. These tests are usually performed by mixing specimens with the coated sur-
faces and allowing time for settling. SPACE is a solid phase variant of the test
(Fig. 1). These tests are relatively rapid, sensitive, and simplistic. A commercially
available LA test for rotaviruses has enabled the immediate processing of stool
suspensions from children admitted to hospital with gastroenteritis during winter
months when a large number of specimens are submitted to the laboratory (greater
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TABLE 1
Detection of Antigens in Clinical Specimens
GEL DIFFUSION
RHEOPHORESIS
COUNTER IMMUNOELECTROOSMOPHORESIS (CIEOP)
THIN LAYER IMMUNOASSAY (TIA)
LATEX AGGLUTINATI ON
SOLID PHASE AGGREGATION OF COATED ERYTHROCYTES (SPACE)
IMMUNOFLUORESCENCE (IF)
IMMUNOPEROXIDASE (IP)
RADIOIMMUNOASSAY (RIA)
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
than 15 per day) and routine electron microscopy (EM) becomes cumbersome. The
LA test usually allows rapid identification of more than half of the infections and
the negatives can be examined for other agents by EM.
Immunofluorescence (IF) and immunoperoxidase (IP) microscopy have been used
for the detection of antigens in infected cells taken directly from the patient [4,5,6J.
Specimens, after fixation, are stable and can be dispatched without time limitations
because infectivity is not a factor. The test may be performed by a direct method in
which antiviral antibody carries the fluorescent label, or an indirect method where
an unconjugated antiviral antibody is detected by a labeled anti-species antibody.
Either or both techniques may be used, depending upon the diagnostic situation. For
example, if only one antigen is being sought, a direct method might be a better
choice (i.e., herpes encephalitis) (Fig. 2). This patient, as well as several others, have
yielded a positive identification of herpes simplex virus (HSV) antigens in brain
biopsy before the administration of antiviral chemotherapy. Investigation of a pa-
tient with respiratory infection when several respiratory viruses may becirculating in
the community would require the use of an indirect technique employing several an-
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FIG. 1. Solid-phase aggregation of coated
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of HSV-infected brain tissue.
tibodies (Fig. 3). The technique is dependent upon highly specific reagents, a
fluorescent microscope, and a certain amount of expertise and patience. Its value
has been demonstrated forthe diagnosis ofrespiratory infections on admision to our
pediatric wards but success is dependent upon collection ofappropriate nasopharyn-
geal specimens containing infected cells.
Radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) are
based on similar principles employing a solid phase coated with a capture antibody
(CA) against a specific virus. Like IF microscopy, direct or indirect techniques have
been developed [7,8]. RIA employs radioactively labeled anti-sera (i.e., iodine) and
a gamma counter is necessary to read the results. The ELISA technique employs an
enzyme attached to an indicator antibody(IA) which causes acolor change whenthe
appropriate substrate is added. This technique may be read by the naked eye or in a
spectrophotometer, depending upon the quality and quantity of analysis that is re-
quired.
Solid-phase immunoassays (RIA and ELISA) are the most sensitive techniques
available for the detection of antigens in clinical specimens. Their optimal use for
rapid viral diagnosis appears to be in a situation where several specimens might be
examined for an antigen in a given run. Most techniques require a day or overnight
incubation to perform the test. Most of these techniques employ one of the three
methods shown in Fig. 4: (1) competitive, (2) direct, or (3) indirect. In the com-
petitive assay [9], enzyme-labeled antigen is mixed with the test sample containing
_~~~
FIG. 3. Indirect immunofluorescence
of throat washing infected with in-
fluenza A virus.
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FIG. 4. Solid-phase immunoassays: A competitive; B direct; C indirect. * Solid phase;A
Capture antibody or antigen; * Antigen or antibody in clinical specimen; ( Detector an-
tibody; E Indicator antibody conjugated;- Conjugated detector antibody;4--Conjugated
competitive antibody or antigen.
antigen, which competes for a limited amount of antibody attached to the solid
phase. Unbound antigen is washed away and the difference in indicator activity be-
tween the specimen and the control is compared. In a direct assay the clinical
specimen is added to a solid phase which has a CA attached to it. Unbound antigen
is washed away before the addition of conjugated detector antibody (DA). The in-
direct test is similar to the direct assay employing a CA and DA, but the DA is not
conjugated. Instead, a third conjugated IA, which is anti-species to DA, is used.
This approach has become popular for ELISA because of the availability of IA en-
zyme conjugates from commercial sources. A number of solid phases have been
used, including test tubes, microtiter plates, beads, filter paper discs, and resins.
The type of solid phase will dictate the kinds of instrumentation to be used in
manipulation of the various steps in the procedure. Immunoassays have been suc-
cessfully applied for the detection of hepatitis A virus (HAV) [10], hepatitis B virus
(HBV) [11], rotavirus [12,13], adenovirus [14,15], herpes simplex virus (HSV)
[16,17], respiratory syncytial virus (RSV) [18], influenza A virus [19,20,21],
cytomegalovirus (CMV) [22], and Coxsackie viruses [23,24], and commercial kits
are becoming available for several. Table 2 shows a small comparison of the ability
of EIA and electron microscopy (EM) to detect rotavirus in stools from patients
with gastroenteritis. Thus we have used EIA for rotavirus antigen detection in
clinical specimens to facilitate processing large numbers of specimens as cited above
employing LA.
Recently, hybridoma technology has enabled the use of monoclonal antibodies in
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TABLE 2
Comparison of Direct Electron Microscopy (EM) and
Direct Enzyme-Linked Immunosorbent Assay (ELISA) on
Feces from Patients with Gastroenteritis, Hamilton, Canada, 1982
SPECIMENS ELECTRON MICROSCOPY DIRECT ELISA'
POSITIVE NEGATIVE POSITIVE NEGATIVE
120 100 20 103** 17
* ROTAZYME (ABBOTT LABORATORIES, N. CHICAGO)
** THREE ELISA POSITIVE/EM NEGATIVE SPECIMENS WERE POSITIVE BY
EM AFTER REACTING WITH ROTAVIRUS ANTISERUM.
these assays. Using polyclonal CA and group- and type-specific monoclonal an-
tibodies to HSV as detector reagents, we were able to establish cutoff values (.05 or
.025) in an ELISA test which identified avirus isolate as HSV (Fig. 5). By construct-
ing optical density ratios with the reactions to the two monoclonals (Fig. 6) all
isolates falling above 1.5 weretype 1 andbelow weretype2. In acomparison with an
IF technique and restriction endonuclease analysis the ELISA test was 100 percent
sensitive and specific for identification and typing (Table 3). Thus this methodology
enables us to obtain a more rapid diagnosis when needed by assaying infected cell
culture fluids after 24 hours' incubation and providing virus typing at the same time.
The assay's sensitivity on clinical specimens, however, was only78 percent ofthat on
tissue culture positives.
DETECTION OF EARLY ANTIBODY RESPONSES
Early antibody (IgM) responses may be detected relatively rapidly after the onset
of symptoms in some infections. Traditional techniques for their separation and
measurement are shown in Table 4. Density gradient centrifugation and column
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FIG. 5. Establishment of cutoff values for
identification ofHSV employing monoclonal an-
tibodies in an enzyme immunoassay.
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TABLE 3
Identification and Typing of HSV by Immunofluorescence (IF),
Enzyme Immunoassay (EIA), and
Restriction Endonuclease (RE) Analysis
IF EIA RE ANALYSIS
IDENTIFICATION TYPING
HSV TYPE I 45 45/45 45/45 22
HSV TYPE II 30 30/30 30/30 14
TOTALS 75 75/75 75/75 36
TABLE 4
IgM Antibody Measurement
SEPARATION - SUCROSE DENSITY GRADIENT
- GEL FILTRATION
- STAPHYLOCOCCAL PROTEIN A
- 2-MERCAPTOETHANOL
DETECTION - HEMAGGLUTINATION INHIBITION
- ELECTROPHORESIS
- RADIOIMMUNOASSAY
- ENZYME LINKED IMMUNOSORBENT ASSAY
- ETC.
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TABLE 5
Solid-Phase IgM Assays
(SEPARATION AND DETECTION IN THE SAME TEST)
IMMUNOFLUORESCENCE
RADI OIMMUNOASSAY
ENZYME IMMUNOASSAY
ERYTHROCYTE INDICATORS (SPIT, SPRIST, HIT)
IMMUNOSORBENT AGGLUTINATION ASSAY (ISAGA)
chromatography are probably the most accurate means available for the separation
of IgM. However, these techniques are relatively complex, time-consuming, and ex-
pensive to perform. Consequently not many laboratories would employ them on a
routine basis. Absorption ofthe serum with a preparation ofstaphylococcal protein
A (SPA) has been used with varying success for the detection ofrubella-specific IgM
in order to diagnose recent infection [25]. Similarly, 2-mercaptoethanol has been
used to destroy IgM in sera. A comparison is then made of treated and non-treated
sera for the measurement ofantibody responses. Both ofthese techniques, although
easy to perform, have their problems with specificity of reaction. The products of
separation in any of these methods are usually assayed in standard tests such as
hemagglutination inhibition (HAI), RIA, ELISA, and so on.
There is a trend toward the development of assays which will separate and
measure in the same test (Table 5). IF was one of the earliest approaches to IgM
measurement using infected cells to trap IgM from serum [26-29]. This approach
has the difficulties of creating a uniform expression of antigens and elimination of
adsorption of immunoglobulins to Fc receptors expressed on the surface of virus-
infected cells. Thus more recent approaches use inanimate solid phases (see section
on antigen detection) and indicators conjugated with isotopes, enzymes,
erythrocytes, or latex particles. Figure 7 illustrates the principles of IgM measure-
ment using a capture antigen on the solid phase. The antigen may be adsorbed
CAPTURE DETECT/INDICATE
Ag
1gM ANTI IgM CONJUGATE
(FA, 1125, ENZYME)
IgG + Ag
FIG. 7. Solid-phase IgM assay
SPA + IgG + Ag employing capture antigen.
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directly or stuck to the solid phase with immunoglobulin or a combination of im-
munoglobulin and SPA. Captured IgM is then indicated by an anti-IgM conjugate
(direct test) or through an indirect method. Table 6 summarizes most ofthe capture
antigen IgM systems that have appeared [30-43]. Most ofthe publications have ap-
peared on Epstein-Barr virus (EBV), CMV, and rubella virus. For the diagnosis of
rubella, it is now possible to employ sensitive and specific IgM ELISAs on a single
serum. Thus we have incorporated this test into our serological battery of tests on
patients presenting with signs and symptoms compatible with rubella and on others
whose serological profile contain a negative rubella PHA response and a positive
hemagglutination inhibition or ELISA (IgG) response. Renal allograft patients are
investigated in our laboratory for primary or reactivated BK papovavirus (BKV) in-
fection by testing serum for BKV IgM antibody using a capture antigen RIA.
Figure 8 illustrates specific IgM detection employing antibody to IgM on the solid
phase. This captures all IgM from the serum, but the specific viral IgM can be
targeted by the subsequent addition of viral antigen. The presence of trapped an-
tigen is then indicated (direct or indirect) by a conjugate. Ifthe viral antigen has the
TABLE 6
Publications on Solid-Phase Capture Antigen IgM Assays
VIRUS IFA RIA EIA
EPSTEIN BARR SCHMITZ (1972,78)
JONCAS (1975)
SUMAYA (1982)
HANSHAW (1968)
SCHMITZ (1977)
ROBERTSON (1977)
DORRIES (1980)
KNEZ (1976)
KANGRO (1978,80,82)
JANKOWSKI (1980)
DORRIES (1983)
SCHMITZ (1972,77)
CAPPEL (1978)
ZIEGELMAIER (1981)
DITTMAR (1979)
DORRIES (1980)
FALAKY (1977) KALINO (1977)
BROWN (1970)
ZAPATA (1983)
DORRIES (1980)
COHEN (1968)
IWAKATA (1972)
FORGHANI (1973)
MEURMAN (1977,78)
KANGRO (1978)
FRJ % IGGEMEYER
LOCARNINI (1979)
JORDAN (1981)
KIMMEL (1982)
MORINET (1982)
BURLINGTON (1983)'
NICOLAI-SHOLTEN (1980)
UKKONEN (1980,81)
ZIEGELMAIER (1981)
MEURNAN (1982)
BURGIUERRE (1980)
ERTL (1979)
UKKONEN (1980)
YOLKEN (1978)
VOLLER (1975)
VEJTORP (1978,79)
ZIEGELMAIER (1981)
FORTIER (1982)
HOFMAN (1979)
HACHAM (1980)
COXSACKIE B
CYTOMEGALO-
VIRUS
DENGUE
ECHOVIRUS
HEPATITIS A
HERPES SIMPLEX
INFLUENZA A
PAPOVA
PARAINFLUENZA
POLIOVIRUS
ROTAVIRUS
RUBELLA
TICK BORNE
ENCEPHAL ITIS
VARICELLA
ZOSTERDETECTION OF VIRAL PARTICLES, ANTIGENS, 1gM
DETECT INDICATE
Ag ANTI Ag IgG CONJUGATE
ERYTHROCYTES
FIG. 8. Solid-phase IgM
assay employing capture
antibody.
ability to hemagglutinate, erythrocytes can be used as indicators. Table 7 sum-
marizes the various capture antibody systems that have been described [44-61]. A
majority ofthe papers have appeared since 1978, and most are in the area ofrubella
serology. Tests for hepatitis A and rubella IgM have found their way into routine
use due to commercial efforts. Figure 9 shows a modification of the capture an-
tibody method employing an enzyme-labeled antigen [62-67]. The technique has
been described for CMV, EBV, VZV, and HSV (Table 8) and appears to have the
advantages of simplicity as well as high levels of sensitivity and specificity. Another
TABLE 7
Publications on Solid-Phase Capture Antibody IgM Assays
SPIT RIA EIA
JAMNBACK (1982)
EL-HAGRASSY (1980)
YOLKEN (1981)
FLEHMIG (1978)
CHAU (1983)
DUERMEYER (1978,79)
MOLLER (1979)
GERLICH (1979)
PERRILLO (1983)
ROGGENDORF (1981,83)
SMEDILE (1982)
BURKE (1982) BURKE (1982,82)
VAN DER LOGT (1982)
VAN DER LOGT (1982)
KRECH (1979)
DENOYEL (1981)
BRAUN (1981)
VAN DER LOGT (1981)
MORTIMER (1981) DIMENT (1981)
ISAAC (1982)
VEJTORP (1981)
ROGGENDORF (1981)
HEINZ (1981)
CAPTURE
a
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ANTI 1gM 1gM
VIRUS
CALIFORNIA
ENCEPHALITIS
COXSACKIE B
CYTOMEGALO-
VIRUS
HEPATITIS A
HEPATITIS B
CORE
HEPATITIS B
DELTA
JAPANESE B
ENCEPHALITIS
MUMPS
PARAINFLUENZA
RUBELLA
TICK BORNE
ENCEPHALITIS766 CHERNESKY AND MAHONY
CAPTURE DETECT/INDICATE
FIG. 9. Antibody capture
ANTI IgM 1gM Ag CONJUGATE IgM assay employing
(ENZYME) enzyme-labeled antigen.
CAPTURE INDICATE
ANTI 19M
SERUM PASSIVELY Ag ANTI Ag IgG CONJUGATE FIG. 10. Solid-phase competitive
ADSORBED antibody blocking IgM assay.
approach that has been described is shown in Fig. 10. This competitive antibody
blocking test passively adsorbs the test serum to the solid phase then blocks reactive
sites in one ofthe wells before adding antigen and indicator. Differences are then in-
dicative of IgM presence or absence.
Each system mentioned has its inherent problems and advantages [68-73]. Table 9
summarizes the approaches that are required in the two systems to avoid false
positive or negative results.
The best example of the use of solid-phase immunoassays employing systems for
the detection of viral antigens and antibodies is that for viral hepatitis and is il-
TABLE 8
Publications on Solid-Phase Capture Antibody
IgM Assays Using Enzyme-Labeled
Detector Antigen
CYTOMEGALOVIRUS SCHMITZ (1980)
KRECH (1982)
VAN LOON (1981)
EPSTEIN BARR VIRUS SCHMITZ (1982)
HERPES SIMPLEX VIRUS VAN LOON (1981)
VARICELLA ZOSTER SUNDQVIST (1982)767 DETECTION OF VIRAL PARTICLES, ANTIGENS, IgM
TABLE 9
Approaches to Eliminate Non-Specific Reactions to
Solid-Phase IgM Assays
ASSAY APPROACHES
CAPTURE ANTIGEN 1) TREAT SERUM WITH STAPHYLOCOCCAL PROTEIN A
OR ANTI IgG ANTISERUM TO REMOVE IgG.
2) REMOVE RHEUMATOID FACTOR FROM SERUM BY
IgG COATED LATEX, HEAT AGGREGATED IgG, ETC.
3) USE FAB FRAGMENT CONJUGATES.
CAPTURE ANTIBODY 1) USE SEVERAL DILUTIONS TO DETECT INTERFERENCE
BY ENDOGENOUS 1gM.
2) USE FAB FRAGMENT CONJUGATES.
3) CERTAIN ANIMAL SPECIES BETTER THAN OTHERS
FOR DETECTOR REAGENTS.
lustrated in Fig. 11. A single serum collected during the acute phase ofillness can be
tested forhepatitis B surface antigen (HBsAg) and HAV IgM. The presence ofeither
of these markers thus provides a diagnosis within a day. The presence of core an-
tibody (anti-HBc) and absence of anti-HBs (antibody to surface antigen) may mean
recent infection with HBV, and a second serum should be requested or a test per-
formed on the first serum for anti-HBc IgM. By the process of elimination of HBV,
HAV, CMV, and EBV the patient may be diagnosed as having non-A, non-B
hepatitis. Assays for detection of markers of non-A, non-B may soon become
available [74]. Using the tests illustrated in Fig. 11 we have had many occasions to
perform "stat" testing on health care workers' and patients' sera involved in a
needlestick accident and to provide recommendations for the appropriate use of
hepatitis B immune globulin (HBIG). Similar testing has identified HBsAg mothers
and recommendations for the use of HBIG and vaccine for their babies. Identifica-
tion of HAV cases have enabled appropriate immunization of their close contacts
with immune serum globulin.
FIG. 11. Rapid testing for viral hepatitis.CHERNESKY AND MAHONY
TABLE 10
Direct Examination of Clinical Specimens by
Electron Microscopy
FLUID
GASTROENTERITIS, CONGENITAL INFECTION,
SKIN ERUPTIONS, MENINGITIS, PHARYNGITIS
TiSSUE
ENCEPHALITIS, WARTS, LUNG, KIDNEY
DETECTION OF VIRAL PARTICLES
Electron microscopy (EM) techniques are most applicable for the investigation of
infections when virus may be present in specimens in concentrations of at least 107
particles per ml [75]. Specimens such as feces, vesicle fluid, brain tissue, wart tissue,
urine, or serum can be negatively stained with minimum preparation to yield
positive results.
Diseases for which EM can play a role in rapid diagnosis include: gastroenteritis,
herpes simplex infections, varicella zoster, variola, vaccinia, pustular contagious der-
matitis, molluscum contagiosum, warts, and congenital cytomegalovirus (Table 10).
Rotaviruses (Fig. 12), adenoviruses, picornaviruses, astroviruses, caliciviruses,
coronaviruses, and Norwalk agents have been viewed in feces from patients with
gastroenteritis [76]. We use the technique on a daily basis to diagnose hospitalized
patients upon admission for purposes of isolation and reduced nosocomial spread.
Patients presenting with vesicular lesions (ex- or enanthematous) mayyield herpes
simplex, varicella (Fig. 13), or vaccinia viruses in vesicle fluid. The EM morphology
ofthe herpes viruses allows identification to group, and other laboratory techniques
are needed fortyping. EM can be used to detect herpes virus particles inbrain biopsy
material from a patient with encephalitis (Fig. 14), although EM has not been as sen-
sitive as FA (see above). Human papillomavirus (common warts), Orf virus, and
molluscum contagiosum pox virus can be viewed in homogenates of solid biopsy
tissue.
FIG. 12. Rotavirus particles in feces from a patient with
gastroenteritis. PTA. Bar represents 100 nm.
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FIG. 13. Varicella zoster virus particle in vesicle fluid from a
patient with chickenpox. PTA. Bar represents 100 nm.
Cytomegalovirus (Fig. 15) is usually present in high concentration in the urine of
congenitally infected infants [77] but may require some form of enhancement [78].
The most appropriate laboratory technique for the preparation of clinical
specimens is negative staining. Thin sectioning techniques have limited applicability
to rapid diagnosis. However, a rapid embedding method that takes only two hours
has been described [79] and thin sectioning is useful where speed of diagnosis is not
important.
The basic requirements for negative staining have been described in detail by
Almeida [80]. The most commonly used stain is phosphotungstic acid (PTA) as a
2-4 percent solution adjusted to a pH of6 to 8, with 1 N potassium hydroxide, and
stored as a working solution at 4°C. Formvar-carbon coated 400 mesh copper grids
provide the most versatile characteristics for specimen viewing. Adisposal container
of hypochlorite or similar solution should be used for discarding contaminated
materials and a flame present for decontamination of forceps.
Fluid specimens are centrifuged for one hour at 15,000 g with resuspension ofthe
pellet in a small amount of distilled water before staining [81]. A more rapid and
simpler technique involves placing a drop of the specimen on a drop of sterile dis-
tilled water sitting on a waxed surface (Fig. 16). A grid held by fine forceps is touched
FIG. 14. Herpes simplex virus
nucleocapsid in brain tissue. PTA. Bar
represents 100 nm.
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FIG. 15. Cytomegalovius in urine
from a congenitally infected infant.
PTA. Bar represents 100 nm.
to the drop, held upright, and stained with a drop of PTA. Excess fluid is removed
with a torn strip of filter paper, after which the specimen is dried before examining
in an EM. The total process takes about five minutes. Application ofcentrifugation
is helpful in making a preparation ofbetter quality and often depends on the type of
clinical specimen submitted. Feces can be prepared by making a 10-20 percent
suspension in distilled water. Clarification in a bench centrifuge may be necessary
for some suspensions; however, rotaviruses are usually easily seen without cen-
trifugation.
Vesicle fluid should be collected from unbroken lesions using a tuberculin syringe
containing a small amount of distilled water. A sheath should be placed over the
needle, and tape applied to the plunger and sheath; then the syringe should be
transported to the laboratory inside an appropriate container. Urine which is cloudy
shouldbe clarified bycentrifugation at 2,500 g for 30 minutes. The supernatant fluid
will usually yield virus more readily ifas large a volume as possible is centrifuged for
one hour at 15,000 gwith staining ofthe resuspended pellet. Techniques ofenhance-
ment have proven useful for urine specimens. Serum contains many low molecular
weight proteins which need to be washed out by diluting with an equal volume of
distilled water. The centrifugation step is necessary and mayrequire recentrifugation
to enable a clean specimen.
Biopsy or autopsy tissue is cut into small (1 mm) cubes and placed on a metal
planchet, which enables several cycles of freezing and thawing. An alternate method
involves mechanical homogenization using a mortar and pestle or homogenizer.
Following this, a relatively smooth suspension can be achieved by mixing with small
amounts of distilled water using a fine-bore pasteur pipette. Best results are then
achieved by differential centrifugation before staining with PTA.
Conjunctival scrapings usually contain small amounts of tissue. CSF will seldom
^ SPEC IMEN STAIN
GRID
_|^TER t _ RCE~~~~~~~~~CPS DISTILLED G PA
GRID LTER PAPER
FIG. 16. Negative staining procedure for electron microscopy.
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TABLE 11
Electron Microscopy Visualization
Enhancement Techniques
1. Pseudoreplication
2. Agar Gel Diffusion
3. Ultracentrifugation
4. Immune Electron Microscopy
yield a virus [82]. Both ofthese specimens should be processed by the rapid staining
technique. Sputum specimens should be diluted in saline and then homogenized or
treated with 20 percent n-acetyl cystein. Differential centrifugation or some form of
enhancement is usually necessary to concentrate the specimen. If concentrations of
viruses are lower in these specimens or others, techniques to enhance visualization
are necessary (Table 11). Both pseudoreplication [83] and gel diffusion [84] concen-
trate the virus particles by allowing the fluid phase to pass through agar. Using
ultracentrifugation techniques, both influenza A and parainfluenza 3 viruses were
seen in throat washings from patients (Figs. 17 and 18). Using solid phase immune
electron microscopy techniques [85] we were able to concentrate BK virus 100- to
1,000-fold (Fig. 19). Similarly, by coating SPA treated grids with rabbit antiserum
to CMV, the method was able to detect virus in urine from CMV-infected kidney
allograft patients (Fig. 20).
FIG. 17. Influenza A virus particles in
throat washings following ultracentrifuga-
tion. PTA.
11111:huh FIG. 18. Par"influenzatype 3 virus particles in
throat washings following ultracentrifugation on
an airfuge. PTA. Bar represents 100 nm.
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4~~~~~
* ^ g FIG. 19. Solid phase immune electron '..- '__t microscopy preparation of BK virus. A
.. .. .. . .Uranyl acetate. Bar represents 1,00 nm.
FIG. 20. Solid-phase immune electron
microscopy preparation of cytomegalovirus in
________nby u ri ne. Grid was treated with staphylococcal pro-
tein A and anti-CMV antibody. Uranyl acetate.
Bar represents 100 nm.
COMMENT
Table 12 lists the various techniques employed in rapid viral diagnosis. More than
one approach may be necessary to uncover a viral etiology in a particular patient.
Knowledge of test availability coupled with clinical information should lead to a
diagnosis in sufficient time to influence patient and/or population management or
treatment.
TABLE 12
Rapid Viral Diagnostic Techniques
1. CULTURE
2. MICROSCOPY
3. DETECTION OF ANTIGENS IN CLINICAL SPECIMENS
4. DETECTION OF EARLY ANTIBODY RESPONSES
5. DETECTION OF NUCLEIC ACIDS OR ENZYMES
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